marketcap
Facebook
Twitter
Telegram
Report an ErrorAdamas Pharmaceuticals, Inc. Financial Ratios 2011-2024 | ADMS
Annual Financial Ratios Adamas Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.8 | -1.3 | -1.8 | -9.9 | -5.4 | -6.0 | 24.4 | - | - | - |
P/S |
2.2 | 2.6 | 7.0 | 1551.0 | 564.4 | 162.0 | 4.5 | - | - | - |
EV/EBITDA |
-5.1 | -2.2 | -2.7 | -10.3 | -5.0 | -4.9 | 10.1 | - | - | - |
PEG |
-0.06 | -0.06 | 0.08 | 0.23 | -1.71 | 0.01 | -0.29 | - | - | - |
P/B |
-3.3 | -158.1 | 2.7 | 13.4 | 2.4 | 2.7 | 1.7 | - | - | - |
P/CF |
-3.2 | -1.7 | -2.3 | -13.0 | -6.5 | -6.4 | 10.0 | - | - | - |
ROE % |
114.86 | 11778.95 | -145.74 | -135.33 | -45.44 | -44.59 | 6.95 | - | - | - |
ROA % |
-47.82 | -64.87 | -55.79 | -48.07 | -42.15 | -40.24 | 6.34 | - | - | - |
ROCE % |
-51.86 | -68.22 | -54.63 | -51.85 | -45.95 | -49.12 | 12.46 | - | - | - |
DSO |
45.6 | 47.0 | 68.1 | 878.3 | 613.9 | 1062.4 | 3.4 | - | - | - |
DIO |
1306.3 | 778.6 | 2952.9 | 36585.9 | - | - | - | - | - | - |
DPO |
384.0 | 1024.8 | 3788.4 | 83262.9 | - | - | - | - | - | - |
All numbers in USD currency